These trials aim to evaluate the reduction in serum uric acid levels and the incidence of gout flares
The short answer is: not necessarily, and the transition can be managed to minimize any disruption to your progress
Dehydration can increase blood viscosity and clot risk independently of medication choice
GLP-1 agonists and dual GIP/GLP-1 agonists work best alongside a healthy lifestyle
Tirzepatide is approved by the US Food and Drug Administration (FDA) to reduce weight in adults with: Obesity Overweight plus at least one weight-related condition, like type 2 diabetes, high blood pressure, or high cholesterol Zepbound comes in a single-dose self-injectable pen that goes under the skin of your belly, thigh, or upper arm
This short-term model suits patients needing rapid weight reduction for a specific event or as a bridge to lifestyle modification, but does not address chronic weight management